Evidence map›Paper›PMID 38322841›Full record

ArticleHeliyon2024

Robotic

Aldo Rocca, Pasquale Avella, Andrea Scacchi, Maria Chiara Brunese, Micaela Cappuccio, Michele De Rosa, Alberto Bartoli, Germano Guerra, Fulvio Calise, Graziano Ceccarelli

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aldo RoccaDepartment of Medicine and Health Science "V. Tiberio", University of Molise, Campobasso, Italy.
Pasquale AvellaHepatobiliary and Pancreatic Surgery Unit, Pineta Grande Hospital, Castel Volturno, Caserta, Italy.
Andrea ScacchiGeneral Surgery Department, University of Milano-Bicocca, Milan, Italy.
Maria Chiara BruneseDepartment of Medicine and Health Science "V. Tiberio", University of Molise, Campobasso, Italy.
Micaela CappuccioDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy.
Michele De RosaGeneral Surgery Department, ASL 2 Umbria, San Giovanni Battista Hospital, Foligno, Italy.
Alberto BartoliGeneral Surgery Department, ASL 2 Umbria, San Giovanni Battista Hospital, Foligno, Italy.
Germano GuerraDepartment of Medicine and Health Science "V. Tiberio", University of Molise, Campobasso, Italy.
Fulvio CaliseDepartment of Medicine and Health Science "V. Tiberio", University of Molise, Campobasso, Italy.
Graziano CeccarelliGeneral Surgery Department, ASL 2 Umbria, San Giovanni Battista Hospital, Foligno, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Surgical resection is still considered the optimal treatment for colorectal liver metastasis (CRLM). Although laparoscopic and robotic surgery demonstrated their reliability especially in referral centers, the comparison between perioperative outcomes of robotic liver resection (RLR) and open (OLR) liver resection are still debated when performed in referral centers for robotic surgery, not dedicated to HPB. Our study aimed to verify the efficacy and safety of perioperative outcomes after RLR and OLR for CRLM in an HUB&Spoke learning program (H&S) between a high volume center for liver surgery and high volume center for robotic surgery. Methods: We analyzed prospective databases of Pineta Grande Hospital (Castel Volturno) and Robotic Surgical Units (Foligno-Spoleto and Arezzo) from 2011 to 2021. A 1:1 propensity score matching (PSM) was performed according to baseline characteristics of patients, solitary/multiple CRLM, anterolateral/posterosuperior location. Results: 383 patients accepted to be part of the study (268 ORL and 115 RLR). After PSM, 45 patients from each group were included. Conversion rate was 8.89 %. RLR group had a significantly lower blood loss (226

Indexed as

Colorectal liver metastasesHub and spoke programLearning programOpen liver surgeryRobotic liver resection

Identifiers

PMID38322841
PMCPMC10844024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.